Ranked second in the nation by U.S. News & World Report, we are committed to providing state-of-the-art diagnosis, treatment and rehabilitation for adults and children with rheumatic and immunologic diseases. These diseases vary from the simple to complex and mild to life-threatening. They include bursitis/tendonitis, osteoporosis, osteoarthritis, rheumatoid arthritis, gout, pseudogout and multiple other forms of arthritis, systemic lupus, vasculitis, fibromyalgia and others.
In every instance, there are opportunities to improve the quality of life and enhance longevity. Achieving disease control is almost always within our grasp, but cures are more elusive. That is why we are engaged in research that explores mechanisms of disease, innovative treatments and studies of outcomes that measure the success of new diagnostic tools and therapies.
It is critical that the physician thought-leaders in our Department pass on their knowledge to the next generation of doctors. Consequently, our efforts to provide excellent care are duplicated in state-of-the-art training for our students at the Lerner College of Medicine, residents, subspecialty fellows and our most advanced post-doctoral care trainees.
